Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients

The current retrospective study involving a total of 1607 patients was designed to identify clinical and molecular variables that were predictive of inferior myelofibrosis‐free survival (MFS) in WHO‐defined essential thrombocythemia (ET), utilizing three independent patient cohorts: University of Fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Loscocco, Giuseppe G., Guglielmelli, Paola, Gangat, Naseema, Rossi, Elena, Mannarelli, Carmela, Betti, Silvia, Maccari, Chiara, Ramundo, Francesco, Jadoon, Yamna, Gesullo, Francesca, Ceglie, Sara, Paoli, Chiara, Pardanani, Animesh, De Stefano, Valerio, Tefferi, Ayalew, Vannucchi, Alessandro M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293196/
https://www.ncbi.nlm.nih.gov/pubmed/34424575
http://dx.doi.org/10.1002/ajh.26332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293196/
https://www.ncbi.nlm.nih.gov/pubmed/34424575
http://dx.doi.org/10.1002/ajh.26332

Ejemplares similares